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Abstract
This article explores the relation between the meaning of what constitutes ‘evidence’ in the Euro-
pean Commission (EC) and the Health in All Policies (HiAP) concept. Since the 2006 Finnish EU
presidency, HiAP is regularly referred to by the Commission, but has not yet been implemented as
an overarching political vision. While there is a growing literature on technical implementation of
HiAP, little work has delved into the political obstacles to HiAP. This article explores three ways
in which the dominant meaning of ‘evidence’ in the EC reinforces neoliberal institutional charac-
teristics in a way that undermines HiAP: The problematization of health reinforces constitutional
asymmetry; the definition of ‘EU added value’ hampers positive integration; and the politicization
of evidence strengthens the Better Regulation meta-regulatory agenda. The article suggests that the
meaning of evidence in the EC reinforces neoliberal rationality present at institutional level, and
calls for more dialogue across public health ontologies.
Keywords: EU governance; evidence; politics of health; health in all policies; discourse analysis;
health promotion
Introducing ‘Health in All Policies’ (HiAP)
In the European Union (EU), non-communicable diseases (NCDs) are the leading cause
of death, disease and disability. An estimated 91.3 per cent of deaths and 86.6 per cent
of disability-adjusted life years are caused by NCDs within the EU28 (EU Science
Hub, 2019). They are often preventable and determined by modifiable factors such as
diet, smoking, alcohol consumption and physical activity. However, there is a growing
understanding that targeting public health interventions solely at changing people’s
behaviour is insufficient and even results in ‘victim-blaming’ (WHO, 2008; Ayo, 2012;
Baum and Fisher, 2014; WHO, 2018a). In turn, public health researchers are increasingly
concerned with understanding how social, macroeconomic and political factors drive
the NCD burden (Labonté, 1998; Bambra et al., 2005; Navarro et al., 2006;
Mackenbach, 2014; Ottersen et al., 2014; Kickbusch, 2015; Schrecker, 2016; Gkiouleka
et al., 2018). Their work shows how health is mainly influenced by policies outside the
health sector, and consequently highlights the need to consider health across policy
sectors.
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One way this understanding of complexity was taken up and transposed into policy
recommendation, was through the Health in All Policies (HiAP) approach. HiAP can
be defined as: ‘[…] an approach to public policies across sectors that systematically takes
into account the health and health systems implications of decisions, seeks synergies and
avoids harmful health impacts, in order to improve population health and health equity.’
(Leppo et al., 2013, p. 6).
Rather than a pre-defined action plan, HiAP represents a way of working, in which
societal health and wellbeing is considered a priority in all areas of policy-making. This
approach recognizes that all public policy areas have an impact on health directly or
indirectly, especially through influencing socioeconomic equity (Leppo et al., 2013).
The essence of HiAP is normative and can be traced back to the Alma-Ata Declaration
of 1978 and the WHO ‘Health for All’ strategy (WHO, 1978, 1981). HiAP was raised
on the EU agenda most notably during the 2006 Finnish presidency (Ståhl et al., 2006).
Indeed, HiAP is relevant not only to local level policies, but also to policies at national,
supranational and global level. Given the complexity of health determinants, health
promotion at local level is likely to have limited effectiveness if European policies with
predominantly non-health interests (such as internal market, competition, trade and fiscal
coordination) are not considered through a HiAP lens (Ståhl et al., 2006, p.14). And while
costs of health intervention in non-health policy areas tend to be overestimated, the
long-term benefits resulting from health and wellbeing promotion are often more difficult
to quantify (Sihto et al., 2006; Smith et al., 2010a).
HiAP is both about ‘technical’ health mainstreaming, and about the adoption of a
‘political’ overarching vision for a healthier, more just and sustainable society (Ståhl
et al., 2006; Leppo et al., 2013). The majority of research on HiAP has focused on
technical implementation,1 and little has been said about political challenges to HiAP,
including in the EU (Oneka et al., 2017). However, investigating how power plays out
in the uptake (or lack thereof) of HiAP at EU level could help better understand why,
despite a particularly rooted neoliberal rationality prevailing in the EU governance, the
HiAP concept has nevertheless emerged and become routinely referenced (for example:
EU Council, 2006, 2010; European Commission, 2007, 2009, 2017a). Most importantly
it would allow to better understand some of the limits to taking up HiAP as a normative
vision.
Due to its technical/political duality, HiAP carries an inevitable level of vagueness,
and its meaning requires contextual adaptation. With the recognition that all policy areas
impact on health, HiAP opens up a terminological ‘Pandora’s box’ of what qualifies as
public health promotion, and whether ‘health’ remains an appropriate term when used
in such an all-encompassing way (Synnevåg et al., 2018). Such use of language runs
the risk of being perceived as ‘health imperialistic’ (Banken, 2001; Kemm, 2001). This
terminological debate calls for a more explicit discussion of the normative aspects of
HiAP, which again justifies studying HiAP from a political science perspective. This
article presupposes a fluid understanding of health as physical, mental, social, cultural
1Since the 2013 Helsinki Statement on Health in All Policies, the WHO is providing support for HiAP implementation, such
as how to identify (or create) structures and processes for HiAP, and how to build human resource capacity
(WHO, 2013, 2014a, 2015a, 2018b). For concrete examples and technical guidance for HiAP implementation, see also
WHO (2014b, 2015b).
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and spiritual wellbeing, and in turn sees HiAP as a way to foster societal wellbeing
broadly understood, rather than a health imperialistic disciplinary agenda. The purpose
of this article is to explore how a mutually reinforcing relation between institutions and
discourse undermines a HiAP uptake, specifically neoliberal institutional characteristics
of the EC, and the dominant meaning of evidence within the EC.
Structure of the Article
The remainder of the article is divided into four parts. The first part introduces the
theoretical underpinnings of this article, then outlines its methodological approach. The
second part presents the EC institutional context empirically, before situating it theoreti-
cally. It contextualizes HiAP within the EC institutional setting, emphasizing some of the
neoliberal biases identified in the literature. To do so, it draws on- and explains the con-
cepts of constitutional asymmetry, and the disbalance between positive and negative EU
integration (Scharpf, 1998, 2006; Greer, 2014). However, the article argues that, in order
to get a more nuanced understanding of the obstacles to HiAP, it is necessary to look be-
yond institutions alone and explore how knowledge is produced, in particular the meaning
of evidence.
The third part introduces the role of the Directorate General for Health and Food Safety
(DG SANTE) as a ‘knowledge broker’ empirically, before situating it theoretically. It
explains the importance of evidence and evidence-based policy-making, and unpacks
the dominant meaning of what represents ‘evidence’ in the EC. This is then situated in
relation to the literature critical of evidence-based policy-making, and specifically
Parkhurst’s (2017) notion of evidence-based policy-making biases.
The fourth and final part explores how the dominant meaning of evidence and institu-
tional factors interact in a way that reinforces a dominant neoliberal rationality and under-
mines HiAP. Three dimensions are developed: the problematization of health as an
economic investment and its relation to constitutional asymmetry in the EU; the definition
of EU added value and its influence on positive integration; the politicization of evidence
and its relation to the Better Regulation agenda.
While dominant discourses need to be understood in their institutional contexts, the
article draws attention to the reproduction of the dominant meaning of evidence occurring
in spaces outside the EC. This is especially relevant in the context of public health policy,
which is rooted in a positivist, hypothetico-deductive research paradigm. This paradigm
however, faces shortcomings when used to research political determinants of health
(Mykhalovskiy et al., 2019). Ultimately, the article suggests that challenging the limits
and constraints of HiAP in a neoliberal setting needs to go alongside promoting more
dialogue between (positivist and post-positivist) ontologies in the study of political
determinants of health, and calls for the need to foster more explicitly diverse relation-
ships between research and policy.
Theoretical Underpinnings and Methodological Approach
To study ideas in institutional settings, the article considers the role of both institution and
discourse (Panizza and Miorelli, 2013; Larsson, 2015; Schmidt, 2017). The term
discourse is used to refer to ‘ways of thinking and speaking about aspects of reality’,
and can shed light on the ‘inextricable link between power and knowledge’ (Cheek, 2012,
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p. 356). ‘Institutions’, here, are defined as constraining and enabling constructs
co-constitutive of agents acting within them (Schmidt, 2010, p. 48). Defined as such, in-
stitutions are not simply existing out there, independently of their active and intentional
social construction. They are shaped and constructed by actors themselves. This is an
important consideration in order to avoid overly deterministic conceptualizations of insti-
tutions as immutable entities.
In turn, this article suggests that limiting the analysis to institutional factors, and
neglecting discursive factors, would fail to expose more subtle, often overlooked, obsta-
cles to HiAP. In this case, it would fail to tease out the relation between meaning of
evidence, neoliberal rationality, and orthodox public health ontology. The need to take
into account institution and discourse is driven by the notion that, while both can be seen
as co-constitutive, the latter is more than a path-dependent result of institutional power
dynamics.
Discourses, and the meanings they carry, can be seen as manifestations of power pres-
ent in language (Belsey, 2002). They are not neutral and independent of each other, but
contain normative assumption and worldviews, shaping a ‘system of meanings’ which
contributes to creating dominant rationalities (Bacchi, 2012; Panizza and Miorelli, 2013;
Flear, 2015). One well-documented such rationality, which clashes with HiAP and the
idea of fostering health equity, is neoliberalism. Neoliberalism refers to the widespread
governance rationality which promotes market liberalization and economic growth while
curtailing public expenditure, and which at the same time shapes the social sphere along
the same rationality, by disciplining citizens to become free yet responsible, entrepreneur-
ial subjects (Tickell and Peck, 2002; Rose et al., 2006; Joseph, 2012; Parker, 2013).
Exploring the reproduction of neoliberal rationality, consequently, cannot be limited to
analyzing institutional factors, but should also occur in discourses, for this can lead to
uncovering less obvious spaces of neoliberal reproduction.
Methodological Approach
This article’s focus was guided by 28 semi-structured elite interviews undertaken with 29
participants between March 2018 and July 2018 in Brussels and Luxembourg. The re-
search project was initially intended to explore knowledge production in the EU Platform
for action on diet, physical activity and health, and its limits to addressing political
determinants of NCDs. Interview participants were eight officials of EU health advocacy
groups, eight of the EC (seven current and one former official), three of the European
Parliament (EP) (one MEP, one MEP assistant and one former MEP assistant), five
representatives of health ministries of EU member states, four members of associations
representing the interests of the food and retail industry, and one representative of a
research and evaluation company. The interviews were conducted by the researcher
face-to-face (24), over Skype (2), by telephone (1) and via email (1).
The semi-structured nature of the interviews provided flexibility to develop broader
topics, including the evolution of DG SANTE, the EC’s involvement in public health pro-
motion, the role of the EP, and latest policy developments in the area. This created a dif-
ferent picture in which unexpected topics appeared as more important than the original
focus. These topics were investigated in increasing depth (in two cases, interviewees were
contacted a second time to elaborate on the new foci): first, the challenges to
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implementing HiAP. Secondly, the role of evidence in public health promotion: how to
process and review it, how to devise effective assessment methods and identify best prac-
tices. Interviewees were split between a majority who firmly adhered to the dogma of
evidence-based health policy-making, and a few public health policy-makers and advo-
cates who took a critical stance vis-à-vis evidence-based policy-making.
This article’s research question developed as a result of grounded conceptualization
(Belfrage and Hauf, 2017). That means it departed from an initial provisional conceptual-
ization of an issue, which was later modified and re-theorized as a result of fieldwork.
This process brought to the forefront the ontological dilemma in public health between
aspiring to produce ‘normatively neutral’ knowledge, and recognizing that the political
and social dimensions of public health elude objectivity. This dilemma appeared to be
salient in the attempts to implement HiAP, because HiAP refers to both a normative
vision and a technical process. The EC context illustrates these tensions particularly well
because of both its ‘technocratic’ nature and its institutional neoliberal bias. The research
question resulting from this ‘retroductive’ reflection process (Belfrage and Hauf, 2017)
can be articulated as follows: In the EC, how is the dominant meaning of evidence related
to neoliberal institutional dimensions, and how does that undermine a normatively mean-
ingful HiAP?
Based on this question, the interview data as well as publicly available EC documents
were analyzed using a set of theoretical concepts as a lens. These theoretical concepts are:
constitutional asymmetry, negative versus positive integration, and Parkhurst’s (2017) ev-
idence biases. They will each be explained in more detail in the relevant sections below.
These lenses allowed to make sense of pathways between neoliberal institutional dimen-
sions in the EC and meanings of evidence. The documents collected and analyzed were
EC publications concerning HiAP, public health promotion, evidence-based policy-mak-
ing (including Better Regulation guidelines) and overarching EC strategic documents
(including on the EC governance and Juncker priorities).
Contextualizing HiAP within the EU Institutional Setting
Article 168 of the TFEU states that ‘[a] high level of human health protection shall be
ensured in the definition and implementation of all Union policies and activities’. Despite
little to no legislative power on healthcare delivery narrowly understood, growing under-
standing of the inter-sectoral nature of health has led to a growing awareness of how the
EU influences population’s health nonetheless, for example through shaping determinants
of health (Ollila et al., 2006; Koivusalo, 2010; Karanikolos et al., 2013; Jarman and
Koivusalo, 2017; Goldner Lang, 2017). The idea that health is shaped outside the health
policy area, and that it is necessary to foster an inter-sectoral approach to health promo-
tion was well understood by seven of the eight DG SANTE officials interviewed,2 for
example:
When you’re looking at the issues like health determinants or disease prevention and
health promotion, […] you have to look at the entire picture I think. And that’s where
of course changing lifestyles is very difficult because of different factors intervening
2Interviewees 1, 3, 5, 6, 8, 9, 10 out of 1, 3, 5, 6, 7, 8, 9, 10.
Evidence and power in EU governance of health promotion 5
© 2020 The Authors. JCMS: Journal of Common Market Studies published by University Association for Contemporary European Studies and John Wiley & Sons
Ltd
and different cultural aspects, different economic aspects, and it’s only by taking a holis-
tic approach that you can hope to make any progress over time. (Interviewee 1).
Existing research around HiAP and its relevance in the context of health promotion has
made its way to the EC, at least to DG SANTE. When introduced under the Finnish pres-
idency in 2006, HiAP was welcomed by the EU Council at the Employment, Social Pol-
icy, Health and Consumer Affairs Council meeting, during which all of the core messages
of HiAP were stressed: a recognition that health is valuable per se, that it is not merely a
matter of personal choice, and that health determinants are shaped largely in policy areas
outside the health sector. It invited the EC to set out a plan to implement it and include it
in its Health Strategy, as well as to improve the knowledge base and identification of the
EU policies that have an impact on health (EU Council, 2006). A second set of Council
conclusions reiterating the commitments to HiAP was published in 2010 (EU Coun-
cil, 2010). The 2017 Companion Report published by DG SANTE puts forward as its first
conclusion the need to address social determinants of health, the vicious circle between
ill-health and poverty, and that this action requires multi-sectoral collaboration (European
Commission, 2017a).
However, despite the awareness of health policy-makers, a HiAP uptake as part of a
political vision for the EC and a rationality existing beyond public health policy circles,
has not been meaningful so far (Koivusalo, 2010; Ollila, 2011; Leppo et al., 2013;
Greer, 2014). Indeed, HiAP as a political vision for the EC and the EU, in practice, would
entail a radical shift towards a social Europe. Arguably, and amidst the current growth of
far-right Euroscepticism, believers in the European project seek to put a (renewed) em-
phasis on the social pillar of the EU (Ferrera, 2017). While the EU project was primarily
one of economic integration, expectations to strengthen its ‘social logics’ started intensi-
fying as economic integration became deep enough for legal constraints on domestic wel-
fare states to be felt (Scharpf, 2002).
Positive versus Negative Integration
Scharpf explains how ‘negative integration’, which acts to remove barriers to trade and
promote the freedom of the single market, is systematically stronger and faster than ‘pos-
itive’ (that is, market correcting) forms of integration (Scharpf, 1998, p. 164). Because of
the executive power of the EC and the authority of the Court of Justice, negative integra-
tion was depoliticized, whereas positive integration needs political legitimation and a high
level of consensus. This is often hard to achieve due to strongly varying interests and
modes of welfare governance of member states (Scharpf, 2006). Relatedly, Scharpf ex-
plains that, while ‘product related regulation’ guaranteeing quality and safety standards
have been fairly easy to put in place alongside negative integration, ‘process related reg-
ulation’ at EU level, such as those pertaining to labour rights, are not easily justifiable and
agreed upon because they do not directly determine the safety and quality of the end prod-
uct in the market (Scharpf, 2006, p. 854).
In the case of health promotion, this rationale is illustrated in the importance given to
food safety and sanitary and phytosanitary regulations, as opposed to HiAP-inspired
health promotion – despite NCDs being by far the biggest burden of disease in the EU.
Greer (2014) argues that there are three different ‘faces’ through which the EU influences
Charlotte Godziewski6
© 2020 The Authors. JCMS: Journal of Common Market Studies published by University Association for Contemporary European Studies and John Wiley & Sons
Ltd
health: the first one pertains directly to health policies. The second face is the influence of
internal market harmonization on health, which according to Greer is illustrative of the
EU constitutional asymmetry. ‘Constitutional asymmetry’ refers to the priority given to
the economy over the social as intrinsically built into the EU project from the beginning
(see Section Constitutional Asymmetry and the Problematization of ‘Health’). And fi-
nally, the third face, which developed most recently, concerns the EU fiscal governance
and its impact on health, most worryingly the post-eurozone crisis commitments to aus-
terity (Greer, 2014). Promoting health across sector, in turn, would entail considerable
priority shifts and changes not in DG SANTE, but across DGs. Greer goes as far as to ar-
gue that health concerns are not the main driver of EU health policy (Greer, 2009).
Arguably, thus, the EU institutional setting is geared in favour of an economic, neolib-
eral logic of EU integration, which renders a HiAP uptake in the EC unlikely. The EC
however should not be seen as an entirely coherent neoliberal monolith. A space for HiAP
in the EC did emerge, by virtue of growing understanding of the complexity of NCD de-
terminants, but it has not led to a fundamental transformation. For a more nuanced inves-
tigation of the obstacles to HiAP in the EC, it is necessary to look beyond institutions
alone. The next sections analyze how the dominant meaning of what represents legiti-
mate, usable evidence in the EC contributes to the neoliberal bias and to undermining
HiAP as a normative vision.
Unpacking the Meaning of Evidence in the EC Governance of Health Promotion
DG SANTE is a strong supporter of the evidence-based approach to health policy-mak-
ing. This emphasis, when put in relation to the HiAP awareness, points towards a contra-
diction: the simultaneous acknowledgement that public health is political and normative
(when talking about HiAP and inequalities), while aiming to approach this issue apoliti-
cally, following an evidence-based rationale. This suggests that both political and techni-
cal aspects can/need to be disentangled. The EC governance structure has a clear
separation between its political and its technical components (European
Commission, 2017b, p. 3). In the area of health promotion and NCD prevention, this is
reflected by DG SANTE endorsing the role of a knowledge broker. This is aligned with
Article 168, which stresses the responsibility of the EU to facilitate collaboration between
member states, complement their activities and facilitate knowledge exchange (Article
168, TFEU). The 3rd Health Programme gives DG SANTE a mandate to collect and pro-
cess policy evidence, as well as support and facilitate best practice exchange and learning
between member states (European Union, 2014; European Commission, 2017c).
Issue Bias and Technical Bias in Evidence-Based Policy-Making
The concept of evidence-based policy-making was preceded by, and aims to emulate, the
principles of evidence-based medicine (EBM) (Parkhurst and Abeysinghe, 2016). EBM is
embedded in the positivist research paradigm characteristic of applied natural sciences. It
traditionally regards randomized controlled trials as the gold standard and most reliable
type of evidence (Nutley et al., 2013). The adequacy of transposing this approach to so-
cial policy, however, is highly contentious and is being criticized in a growing body of
literature (Petticrew and Roberts, 2003; Sanderson, 2006; Neylan, 2008; Greenhalgh
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and Russell, 2009; Bacchi, 2012; Parkhurst, 2017). It has been argued that this under-
standing of evidence is not useful when dealing with complex, ‘wicked’ problems
(Dryzek, 1990; Sanderson, 2006; Parkhurst, 2017). Parkhurst (2017) categorizes two
main types of problems that follow from the transposition of an EBM approach to public
policy-making. The first one, ‘issue bias’, relates to the risk of depoliticizing politics, that
is the technocratization of inherently political and value-laden policies. This obscures un-
derlying norms and values that are inevitably present in policies, and shuts down possibil-
ities for dialogue around these norms. The second type of bias relates to the risk of
politicization of science, the instrumental (mis)use of scientific evidence for political ends
– ‘technical bias’ (Parkhurst, 2017).
In line with the evidence-based policy-making approach as a replication of the princi-
ples of EBM, legitimate, usable evidence in the EC and DG SANTE is predominantly
conceptualized as quantifiable, measurable and deriving from a positivist approach that
isolates causal links. This however neglects the key difference that NCD determinants
are largely social rather than medical (Smith, 2013; Parkhurst, 2017). It has already been
suggested that biomedical paradigms of health, with their appeal to normative neutrality,
are often neatly compatible with neoliberalism (Rushton and Williams, 2012; Schrecker
and Bambra, 2015).
The Interaction between Meaning of Evidence and Institutional Context
This final section of the article seeks to tease out the mutually reinforcing relation be-
tween the two previous sections – the institutional neoliberal biases of the EC and the
meaning of evidence – and reflect on how it undermines HiAP. It draws on the theoretical
concepts explained in both previous sections (negative/positive integration and constitu-
tional asymmetry, and Parkhurst’s notion of biases in evidence-based policy-making) to
outline three ways in which the meaning of evidence reinforces neoliberal institutional
characteristics of the EC, and in turn undermines a normatively meaningful HiAP uptake:
first, the dominant meaning of evidence shapes the problematization of health in a way
that strengthens constitutional asymmetry. Secondly, the dominant meaning of evidence
informs how EU added value is defined in a way that challenges possibilities for positive
integration. These two points relate to Parkhurst’s issue bias. Thirdly, the dominant mean-
ing of evidence lends itself well to politicization in the context of the EU’s agenda setting
guidelines for how to regulate, the ‘Better Regulation agenda’, which represents an in-
stance of technical bias.
Constitutional Asymmetry and the Problematization of ‘Health’
The rationale for the 2014–20 3rd EU Health Programme illustrates constitutional asym-
metry in the way it is tailored to feed into the current EC’s big political priorities (so-
called ‘Juncker priorities’) largely geared towards economic growth and competitiveness,
and towards creating entrepreneurial citizens as the ‘social’ goal (Juncker, 2014). It claims
that health is a prerequisite for a ‘smart, sustainable and inclusive economy promoting
growth for all’ (European Parliament, 2018, p. 5). The call for more investment in health
3Interviewees 2, 6, 12, 13, 14, 15 out of 1, 2, 3, 5, 6, 7, 9, 10, 11, 12, 13, 14, 15.
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promotion is still dominantly justified in terms of economic gains and increased produc-
tivity rather than referring to social justice and human rights: ‘Deaths from major
non-communicable diseases translate into EUR 115 billion in potential economic loss
each year’ (European Commission, 2017a, p. 10). This economic justification for health
was criticized by six of the 13 health policy-makers interviewed3 (former health
policy-makers and MEP assistants excluded), for example:
Prevention for example, I proposed to appoint a Commissioner for prevention. Because
the money we allocate for health disappears in the hospitals more or less. But prevention
means to work with healthy people and prevention is still not considered as an economic
category but when you land in the hospital then you become an economic category. (In-
terviewee 2).
This justification seemed to be perceived by those interviewees as nevertheless the
only realistic strategy to raise health higher onto the agenda. As this suggests, the eco-
nomic justification for investing in health is difficult to challenge, and ill-health becomes
seen in terms of risk, as an economic burden and a productivity loss to avoid (Flear, 2015;
Smith, 2013;). One of the obstacles to challenging this discourse, this article argues, is the
dominant understanding of what constitutes legitimate research evidence aligned with a
biomedical paradigm of health. In mutual reinforcement with the EU’s constitutional
asymmetry, this meaning of evidence maintains the conceptualization of health as a
means to an end rather than an end in itself. Mobilizing evidence aligned with a view
of health as a medical issue and a financial burden to avoid, precludes a focus on the so-
cial dimensions of health, such as drivers of diet-related NCDs (Bambra et al., 2005; Stahl
et al., 2006; Smith, 2013). Instead, such an understanding of evidence lends itself more to
measuring health impact in financial terms. Yet this task may be bound to fail, for the
complexity and multi-faceted nature of health does not allow a break down into a small
list of measurable indicators. The puzzle of collecting data across member states, defining
indicator and measuring impact was a point highlighted by five interviewees4 as an im-
portant challenge:
[…] when you think of the EU you think of standardized, very strict standardized data
collection that applies for a limited number of indicators. A good example is if you look
at employment you have four or five key indicators that are used at EU level […] In
health we were never able to reach that degree of lightness so we started with something
like a couple of thousands of indicators, and now we have a short list that is under 100.
But even under 100 … it’s not 4 […] (Interviewee 3).
While measuring health impact is certainly an important part of HiAP, the core message
of the HiAP approach is not reducible to health impact assessments alone, especially if the
way impact is defined buys into the conceptualization of health promotion as primarily an
economic investment. In this way, the dominant meaning of evidence risks reducing
HiAP to a list of measures with financially quantifiable benefits, and fails to fundamen-
tally challenge the economic, neoliberal narrative of health promotion as an investment
with high returns. Despite the likelihood that no health policy-maker interviewed would
think of health as merely an economic investment, the assumption that this is a necessary
4Interviewees 1, 3, 6, 7, 16.
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frame, and that a radically different frame would be inadequate, is maintained through the
overarching neoliberal rationality that is manifested in the meaning attached to evidence.
Positive Integration and EU Added Value
‘EU added value’ is an important criteria guiding resource allocation (European
Commission, 2017d, 2018b). Indeed, the upcoming EU Health Budget prioritizes what
is straightforwardly perceived as having greater EU added value, such as collaboration
on rare disease diagnostic and treatment, digitalization of health and care, infectious dis-
ease threats, and supporting EU health system reforms (European Commission, 2018a).
Arguably, the accent put on added value might reflect a need to clearly define the role
of DG SANTE at a time where the mantra ‘[The EU should be] big on big things and
small on small things’ (Juncker, 2014; European Commission, 2017e, 2018b) prevails.
Admittedly, DG SANTE in particular works with a small budget,5 which significantly
constraints what it can do and justifies this type of prioritization. However implementing
HiAP is not the responsibility of DG SANTE alone, and requires an EC-wide, even
EU-wide commitment. When it comes to health and health promotion, EU added value
has been narrowed down along very specifically defined lines. Indeed, the Consumer,
Health, Agriculture and Food Executive Agency (CHAFEA) has elaborated a formalized
‘EU added value score’ from 1 to 10 to evaluate potential funding under the 3rd Health
Programme (European Commission, 2017f). This suggests that EU added value should
be objectively quantifiable. CHAFEA streamlines seven EU added value criteria: best
practice and knowledge exchange; benchmarking; (multi-stakeholder) network building;
addressing cross-border threats; health issues where internal market is strongly concerned
(for example, patient mobility); innovation in healthcare; and optimizing the use financial
resources (avoiding duplications). The executive summary of the mid-term evaluation of
the 3rd Health Programme suggests that it may be sensible to shift the focus away from
issues as complex and broad as NCDs – except for the knowledge sharing angle – due
to the difficulty to clearly define the scope of action and avoid spreading resources too
thinly (European Commission, 2017d, p. 4).
Commonly agreed in interviews6 and present in DG SANTE documents was the no-
tion that one of the most important EU added value in public health promotion is sharing
evidence and best practices (European Commission, 2017a, 2017f). This implies that EU
competencies themselves are of little relevance to health promotion. However, going back
to the HiAP logic and recognizing the complexity and interrelatedness of political deter-
minants of health, EU policies appear indeed much more relevant to health promotion and
NCD prevention (see introduction). To meaningfully take such a broad vision of health
promotion into account would be a complex task related to the more fundamental debate
around promoting a social logic of EU integration.
The meaning of added value as mainly evidence sharing suggests an instrumental re-
lationship between evidence and policy. However, research utilization is far from limited
to an instrumentalist view of research ‘filling a knowledge gap’ and providing ready-to-
use solutions to problems (Weiss, 1979). The research/policy relationship can also be a
5The proposed health budget for 2021–27 amounts to EUR 413 million (European Commission, 2018a). This sum excludes
other funding sources directed towards health, most importantly research funding.
6Interviewees 1, 2, 3, 5, 7, 8, 10, 11, 13, 16, 17, 18.
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more fluid one of awareness raising, where theoretical perspectives slowly inform differ-
ent ways to make sense of issues, potentially redefining policy agenda on the long run
(Weiss, 1977). On the topic of social determinants of health, Smith (2013) explains that
an approach to thinking about evidence and policy efficiency in narrow
problem-solving terms leads to developing health policies that target low
socio-economic groups, following an idea of ‘closing a quantifiable gap’. But it precludes
policies that modify the system which brings about socio-economic inequalities
(Smith, 2013).
Applied to the EU, a narrow understanding of added value related to an instrumentalist
view of the evidence/policy relationship, confines the responsibility to promote health and
tackle NCDs to member states or local authorities, which might implement health promo-
tion policies targeted at vulnerable groups without calling into question the link between
macroeconomic governance and ill-health. This separation between EU affairs and (na-
tional) public health also relates to the difficulty and/or reluctance (justified or not) of
member states to envisage and work towards more ‘positive’ integration. Meanwhile, it
shuts down possibilities to think of structural changes, such as those advocated by the
HiAP approach. In that sense, the meaning of evidence and in particular how the relation-
ship between evidence and policy is thought about, reinforces the neoliberal rationality
prevailing at EU level, as it deters from thinking about potential EU added value that
would lie in fostering structural changes, in moving towards more social EU integration.
Instead, it implicitly confirms the idea that EU added value in health promotion is limited
to evidence exchange between member states.
Better Regulation and Lack of Evidence
There exists a wealth of medical, statistically significant evidence regarding the patholog-
ical effects of poor nutrition or physical inactivity. But as suggested throughout the arti-
cle, isolating the effect of a particular policy, measuring and proving its effectiveness or
harm is often very challenging or even impossible, given the complex, multi-factorial na-
ture of the issue, and the time needed for outcomes to become visible. This does not mean
that research evidence on that matter does not exist, but that it is not necessarily the kind
of evidence that is perceived by the EC as usable, namely narrowly measurable and sta-
tistically significant. In turn, ‘lack of evidence’ can become a justification for inaction.
In the EU, calls from industry for increasingly intensive impact assessments have been
criticized for representing a way to oppose and delay proposals for public health regula-
tions (Smith et al., 2015; Corporate Europe Observatory, 2016).
This issue is particularly relevant in the EC, which mainstreams the Better Regulation
approach across DGs, as a cross-cutting priority. Among other things, Better Regulation
makes mandatory stringent impact assessments of all new major EU policy, and embeds a
culture of close stakeholder consultation (European Commission, 2017g). Some re-
searchers have shown how corporate interest, notably the tobacco industry, lobbied to
shape the impact assessment in a way that prioritizes business’ economic interests over
other kinds of impact, including health (Smith et al., 2010b). The same study shows
how Better Regulation empowers corporate actors by involving them at an early stage,
7Interviewees 4, 15, 19.
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giving them space to challenge potential and existing legislation. The instrumentalization
of evidence as a means to oppose public health legislation, and using complexity as an
excuse for inaction were the main points raised by the three interviewees7 who expressed
critical views towards the role of evidence in public health policy-making:
Impact assessment now has become much more complex. […] It’s also become a battle
ground; so again [regarding] the most recent tobacco control directive. An impact assess-
ment was done […]. And then the industry lobbied against it, called it into question,
complained to the impact assessment board in the EC. So the EC had to, they decided
to commission not just one new impact assessment on the draft directive, but they
commissioned 5 impact assessments. Which built in another 2, 3, 4 years delay. (Inter-
viewee 4).
This article stresses that because the meaning of evidence is narrow and carries much
authority, especially in the technocratic context of the EC, evidence is easily
instrumentalized to oppose public health regulation. This is even more relevant in light
of the Better Regulation governance culture porous to interest representation and lobby-
ism. This ‘technical bias’ is a particularly pervasive lobbying tool, because it consolidates
current power dynamics and a governance culture in which public health and societal
wellbeing is not given priority over other interests. The erosion of the precautionary prin-
ciple (that is, the possibility to regulate based on suspicion of risk in the absence of clear
scientific evidence, see Smith et al., 2015) through increased requirements for a particu-
lar type of evidence undermines possibilities for policies geared towards structural, polit-
ical change, which again limits the scope for a meaningful HiAP uptake.
Conclusion
This article has looked at how the dominant meaning of evidence represents an obstacle to
implement HiAP in the EC. It explored three ways in which the meaning attributed to the
notion of evidence interacts with neoliberal institutional factors and reproduces a neolib-
eral rationality which hinders a normatively meaningful shift towards HiAP. The domi-
nant meaning of evidence shapes the problematization of health in a way that reinforces
constitutional asymmetry. It informs the definition of ‘EU added value’ in a way that pre-
cludes the possibilities to consider positive integration. Finally, it is susceptible to politi-
cization by private interests, especially in the Better Regulation context.
The dominant meaning of evidence does not appear a priori, and should be understood
within the institutional context: indeed, the use of evidence to quantify health investment
in monetary terms, the technocratization of EU added value and the instrumentalization
of evidence by private interests can all be seen as political strategy to maintain the
status quo. In turn, it is by no means argued that the meaning of evidence is the sole,
independent factor that undermines HiAP in the EC. It is nevertheless important not to
reduce discourses to the inevitable result of institutions and political strategy. This article
suggests that the dominant meaning of evidence is also an often overlooked site of
interaction between a biomedical paradigm of health and neoliberalism. Pointing this
out can open up interesting avenues for engagement between critical EU studies and
public health.
Instead of calling for more evidence on HiAP to support its implementation, this article
concurs with Hawkins and Parkhurst (2016) in advocating for the development of a more
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diverse and inclusive understanding of what represents ‘evidence’. More specifically, fos-
tering the multiplicity of ways in which evidence can support policy, based on a ‘good
governance of evidence’ (Hawkins and Parkhurst, 2016). Challenging the narrow mean-
ing of what represents legitimate evidence, and by doing so challenging the instrumental-
ist view of the research/policy relationship in the EU, requires continued efforts to
develop more dialogue between public health and critical EU studies.
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